Archive | CERBIOS-PHARMA SA

Page 2 of 6
Cerbios-Pharma debuts as face-to-face presence at 11th Anniversary HPAPI Summit Boston
Cerbios-Pharma debuts as face-to-face presence at 11th Anniversary HPAPI Summit Boston Learn More >
Cerbios nears completion of new cGMP cytotoxic unit for increased HPAPIs and Payloads production
Cerbios nears completion of new cGMP cytotoxic unit for increased HPAPIs and Payloads production Learn More >
Cerbios-Pharma brings latest CDMO offerings to BIO 2022 in California
Cerbios-Pharma brings latest CDMO offerings to BIO 2022 in California Learn More >
Cerbios-Pharma named as Europe’s Top CMO for 2022
Cerbios-Pharma named as Europe’s Top CMO for 2022 Learn More >
Cerbios-Pharma reaches out to young graduates with distinctive values and continuous development
Cerbios-Pharma reaches out to young graduates with distinctive values and continuous development Learn More >
Cerbios highlights importance of QbD approach to ADC development
Cerbios highlights importance of QbD approach to ADC development Learn More >
Cerbios-Pharma presents QbD approach to optimizing payloads at World ADC Europe 2022
Cerbios-Pharma presents QbD approach to optimizing payloads at World ADC Europe 2022 Learn More >
Cerbios-Pharma returns to DCAT Week in NYC
Cerbios-Pharma returns to DCAT Week in NYC Learn More >
Cerbios-Pharma showcased its Pharmaceutical Services Portfolio at CPhI Worldwide
Cerbios-Pharma showcased its Pharmaceutical Services Portfolio at CPhI Worldwide Learn More >
50264Cerbios-Pharma SF68® SKINActive
Cerbios-Pharma SF68® SKINActive Learn More >
50416Restructured Proveo one stop shop for pharma Antibody Drug Conjugates (ADCs)
Restructured Proveo one stop shop for pharma Antibody Drug Conjugates (ADCs) Learn More >
Cerbios-Pharma presenting benefits of restructured PROVEO service at the World ADC 2021
Cerbios-Pharma presenting benefits of restructured PROVEO service at the World ADC 2021 Learn More >
Page 2 of 6